Dexmedetomidine Versus Propofol for Prolonged Sedation in Critically Ill Trauma and Surgical Patients
Status: | Completed |
---|---|
Conditions: | Hospital, Neurology |
Therapuetic Areas: | Neurology, Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | November 2014 |
End Date: | April 2015 |
The purpose of this study is to assess the efficacy of dexmedetomidine versus propofol for
prolonged sedation in trauma and surgical patients.
prolonged sedation in trauma and surgical patients.
Design: Open-label, single-center prospective study. Setting: Trauma/Surgical Intensive Care
Unit (TSICU) at a Level I academic trauma center.
Patients: Patients 18 years of age or older requiring mechanical ventilation and admitted to
the TSICU Interventions: Patients were randomly assigned based on unit bed location to
receive dexmedetomidine or propofol for sedation.
Unit (TSICU) at a Level I academic trauma center.
Patients: Patients 18 years of age or older requiring mechanical ventilation and admitted to
the TSICU Interventions: Patients were randomly assigned based on unit bed location to
receive dexmedetomidine or propofol for sedation.
Inclusion Criteria:
- Patients were included in the study if they were 18 years of age or older,
- mechanically ventilated,
- placed on the institutional sedation protocol,
- expected to require sedation lasting 24 hours after randomization, and
- admitted to the TSICU and followed by the Trauma/Surgical Service.
Exclusion Criteria:
Patients were excluded for any of the following:
- 72 hours or greater since sedation protocol initiation,
- treatment per the institutional traumatic brain injury (TBI) protocol,
- concomitant continuous infusion of a neuromuscular blocking agent,
- heart rate less than 50 beats per minute,
- mean arterial pressure less than 55 mmHg despite fluid resuscitation and
vasopressors, and
- use of other alpha-2 agonists within 24 hours of randomization.
We found this trial at
1
site
Click here to add this to my saved trials